108 related articles for article (PubMed ID: 31177462)
1. Hypermethylated Genes of MicroRNA in Ovarian Carcinoma: Metastasis Prediction Marker Systems.
Filippova EA; Loginov VI; Burdennyi AM; Braga EA; Pronina IV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Fridman MV; Khodyrev DS; Kushlinskii NE
Bull Exp Biol Med; 2019 May; 167(1):79-83. PubMed ID: 31177462
[TBL] [Abstract][Full Text] [Related]
2. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
[TBL] [Abstract][Full Text] [Related]
3. [Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis].
Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Kazubskaya TP; Kushlinsky DN; Ermilova VD; Rykov SV; Khodyrev DS; Braga EA
Mol Biol (Mosk); 2018; 52(5):801-809. PubMed ID: 30363055
[TBL] [Abstract][Full Text] [Related]
4. [A Group of Hypermethylated miRNA Genes in Breast Cancer and Their Diagnostic Potential].
Filippova EA; Loginov VI; Pronina IV; Khodyrev DS; Burdennyya AM; Kazubskaya TP; Braga EA
Mol Biol (Mosk); 2019; 53(3):421-429. PubMed ID: 31184607
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma.
Braga EA; Loginov VI; Filippova EA; Burdennyi AM; Pronina IV; Kazubskaya TP; Khodyrev DS; Utkin DO; Kushlinskii DN; Adamyan LV; Kuslinskii NE
Bull Exp Biol Med; 2018 Dec; 166(2):253-256. PubMed ID: 30488208
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of methylation of a group of miRNA genes in patients with ovarian cancer.].
Kushlinskii NE; Utkin DO; Loginov VI; Filippova EA; Burdennyy AM; Kushlinsky DN; Pronina IV; Braga EA
Klin Lab Diagn; 2020; 65(5):321-327. PubMed ID: 32298550
[TBL] [Abstract][Full Text] [Related]
7. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
[TBL] [Abstract][Full Text] [Related]
8. Marker Systems Based on MicroRNA Gene Methylation for the Diagnosis of Stage I-II Breast Cancer.
Braga EA; Filippova EA; Loginov VI; Pronina IV; Burdennyi AM; Kazubskaya TP; Fridman MV; Khodyrev DS; Kushlinskii NE
Bull Exp Biol Med; 2019 Dec; 168(2):280-284. PubMed ID: 31782000
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
10. [The hyper-methylated genes microRNA as potential markers of clear-cell carcinoma of kidney].
Beresneva EV; Loginov VI; Khodyrev DS; Pronina IV; Kazubskaya TP; Karpukhin AV; Braga EA; Kushlinskii NE
Klin Lab Diagn; 2017 Jan; 62(1):13-8. PubMed ID: 30615358
[TBL] [Abstract][Full Text] [Related]
11. [Methylation profile of group of miRNA genes in clear cell renal cell carcinoma; involvement in cancer progression].
Beresneva EV; Rykov SV; Hodyrev DS; Pronina IV; Ermilova VD; Kazubskaia TP; Braga EA; Loginov VI
Genetika; 2013 Mar; 49(3):366-75. PubMed ID: 23755536
[TBL] [Abstract][Full Text] [Related]
12. Methylation-associated silencing of
Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases.
Loginov VI; Pronina IV; Filippova EA; Burdennyy AM; Lukina SS; Kazubskaya TP; Uroshlev LA; Fridman MV; Brovkina OI; Apanovich NV; Karpukhin AV; Stilidi IS; Kushlinskii NE; Dmitriev AA; Braga EA
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163224
[TBL] [Abstract][Full Text] [Related]
14. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].
Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA
Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677
[TBL] [Abstract][Full Text] [Related]
15. [Novel miRNA genes hypermethylated in breast cancer].
Loginov VI; Burdennyy AM; Pronina IV; Khokonova VV; Kurevljov SV; Kazubskaya TP; Kushlinskii NE; Braga EA
Mol Biol (Mosk); 2016; 50(5):797-802. PubMed ID: 27830681
[TBL] [Abstract][Full Text] [Related]
16. E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness.
Cheng FHC; Lin HY; Hwang TW; Chen YC; Huang RL; Chang CB; Yang W; Lin RI; Lin CW; Chen GCW; Mai SY; Lin JMJ; Chuang YM; Chou JL; Kuo LW; Li C; Cheng ASL; Lai HC; Wu SF; Tsai JC; Chan MWY
Cancer Sci; 2019 Mar; 110(3):1085-1095. PubMed ID: 30582655
[TBL] [Abstract][Full Text] [Related]
17. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.
Schmid G; Notaro S; Reimer D; Abdel-Azim S; Duggan-Peer M; Holly J; Fiegl H; Rössler J; Wiedemair A; Concin N; Altevogt P; Marth C; Zeimet AG
BMC Cancer; 2016 Feb; 16():102. PubMed ID: 26879132
[TBL] [Abstract][Full Text] [Related]
18. The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma.
He XX; Kuang SZ; Liao JZ; Xu CR; Chang Y; Wu YL; Gong J; Tian DA; Guo AY; Lin JS
Mol Biosyst; 2015 Feb; 11(2):532-9. PubMed ID: 25424171
[TBL] [Abstract][Full Text] [Related]
19. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer.
Kim YH; Lee WK; Lee EB; Son JW; Kim DS; Park JY
Clin Lung Cancer; 2017 Jan; 18(1):e13-e20. PubMed ID: 27444357
[TBL] [Abstract][Full Text] [Related]
20. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
